Related Experiment Video
Updated: Aug 11, 2026

09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Platelet hyporeactivity in very low birth weight neonates
D Rajasekhar1, M R Barnard, F J Bednarek
1Department of Pediatrics, University of Massachusetts Medical School, Worcester, USA.
Thrombosis and Haemostasis
|May 1, 1997
Summary
Platelets in very low birth weight (VLBW) neonates are significantly less reactive than adult platelets. This platelet hyporeactivity may contribute to intraventricular hemorrhage in VLBW infants.
Area of Science:
- Neonatal physiology
- Hematology
- Platelet biology
Background:
- Platelet function studies in very low birth weight (VLBW) neonates are limited due to high blood volume requirements.
- Understanding platelet function is crucial for assessing bleeding risks in preterm infants.
Purpose of the Study:
- To evaluate platelet function in clinically stable VLBW neonates using whole blood flow cytometry.
- To compare the reactivity of VLBW neonatal platelets with adult platelets.
Main Methods:
- Whole blood flow cytometry was employed, requiring only 5 microliters of blood per assay.
- Monoclonal antibodies targeting P-selectin, fibrinogen binding, and GPIb-IX-V complex were utilized.
- Platelet reactivity was assessed in response to thrombin, ADP/epinephrine, and a thromboxane A2 analogue.
Main Results:
- VLBW neonatal platelets demonstrated markedly reduced reactivity compared to adult platelets.
- Key indicators of platelet activation, including P-selectin expression and fibrinogen binding, were significantly lower in VLBW neonates.
- A decrease in GPIb binding was also observed, indicating reduced von Willebrand factor interaction.
Conclusions:
- VLBW neonatal platelets are hyporeactive to common agonists in whole blood.
- This platelet hyporeactivity may be a contributing factor to the increased incidence of intraventricular hemorrhage in VLBW neonates.
- Whole blood flow cytometry is a valuable tool for assessing platelet hyporeactivity in clinical settings.
Related Concept Videos
Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

